EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy

Puja Adi Priatna, Rizki Rahmadi Pratama, Retno Widyowati, Sukardiman Sukardiman

Pharmacognosy Journal · 10.01.2023 · 14 (6s) · 912-916

DOI: 10.5530/pj.2022.14.188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacognosy Journal, online erschienen am 10.01.2023. Verfasst von Puja Adi Priatna und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Priatna, P. A., Pratama, R. R., Widyowati, R., & Sukardiman, S. (2023). Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy. Pharmacognosy Journal, 14(6s), 912-916. https://doi.org/10.5530/pj.2022.14.188

Vancouver

Priatna PA, Pratama RR, Widyowati R, Sukardiman S. Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy. Pharmacognosy Journal. 2023;14(6s):912-916. doi:10.5530/pj.2022.14.188

BibTeX
@article{Priatna2023,
  author = {Priatna, Puja Adi and Pratama, Rizki Rahmadi and Widyowati, Retno and Sukardiman, Sukardiman},
  title = {Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy},
  journal = {Pharmacognosy Journal},
  year = {2023},
  volume = {14},
  number = {6s},
  pages = {912--916},
  doi = {10.5530/pj.2022.14.188}
}
Kostenlos starten →